ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 63

Spine Osteoarthritis Is Associated with All Cause Mortality in Older Men

Charline Estublier1, Roland Chapurlat2 and Pawel Szulc3, 1Rheumatology, Hôpital Edouard Herriot, Pavillon F, Lyon, France, 2Pavillon F Rheumatology, Hopital Edouard Herriot, Lyon, France, 3Epidemiology of Osteoporosis, INSERM UMR 1033, Lyon, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: osteoarthritis and spine involvement

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Public Health: Osteoporosis, Non-Inflammatory Arthritis and More

Session Type: Abstract Submissions (ACR)

Background/Purpose: Hip and knee osteoarthritis (OA) was associated with higher cardiovascular morbidity and mortality. Data on the cardiovascular status in men with spine OA are scarce. We assessed the association of spine OA with all cause mortality and with abdominal aortic calcification (AAC) severity and its progression rate in older men.

Methods: Men aged >50 (n=766) had lateral spine radiographs and blood collection and were followed up prospectively. Spine OA was assessed by Lane’s score (Lane et al., J Rheumatol, 1993). We calculated the total osteophyte score by adding up osteophyte scores for 6 intervertebral levels. We calculated total disc narrowing score (DSN) and total overall grade score similarly. AAC was assessed by Kauppila’s semiquantitative score (Atherosclerosis, 1997). We assessed the association of spine OA with all cause mortality (10 years), AAC severity and AAC progression (7.5 years).

Results:

Moderate and severe osteophytes were found in 85% of men, 72% of men had DSN. During the follow-up, 176 men died. After adjustment for confounders (age, BMI, AAC, smoking, physical activity, leg disability, diabetes, pulmonary diseases, Parkinson disease, 17b-estradiol, 25OHD, GFR, fat mass, vitamin D supplementation, vitamin K antagonists), the total overall grade spine OA score predicted all cause mortality (hazard ratio [HR]= 1.20 per SD increase, 95% confidence interval [95%CI]: 1.01-1.43, p<0.05). After adjustment for confounders, men who had both severe AAC (AAC>2) and severe OA (total overall grade score >8, highest tertile) had higher mortality than the reference group (AAC score ≤2 and total overall grade score ≤8): 51.8 vs 10.3 /1000 person-years; HR= 2.30, 95%CI: 1.34–3.96, p<0.005).

After adjustment for confounders, the odds of severe AAC (AAC>5) increased with total DSN score (HR= 1.44 per SD, 95%CI: 1.11-1.87, p<0.05). The highest tertile of total DSN score was associated with higher odds of severe AAC (adjusted HR= 2.42 versus two lower tertiles combined, i.e. >3 vs 0-3, 95%CI: 1.24-4.73, p<0.005). Finally, probability of long-term AAC stability decreased with increasing total osteophyte score (adjusted HR= 0.66 per SD, 95%CI: 0.49-0.88, p<0.05). The highest tertile of total osteophyte score (>10) was associated with lower probability of AAC stability (adjusted HR= 0.35 versus the lowest tertile, i.e. 0-6, 95%CI: 0.18-0.71, p<0.01).

OA therapy (non-steroidal anti-inflammatory drugs, analgesics) had no impact on the results of all the above analyses.

 Conclusion: Older men with severe spine OA have greater AAC severity, faster AAC progression and higher all-cause mortality. Higher mortality may be partly mediated by lower physical activity and metabolic abnormalities.


Disclosure:

C. Estublier,
None;

R. Chapurlat,
None;

P. Szulc,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spine-osteoarthritis-is-associated-with-all-cause-mortality-in-older-men/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology